Andy Roddick defends Serena Williams' GLP-1 weight loss amid comeback talk

Former tennis star Andy Roddick has voiced support for Serena Williams' use of GLP-1 medication in her weight-loss efforts, suggesting it could aid a potential return to the court. Williams has shared how the treatment improved her health, while speculation grows following her inclusion in the anti-doping pool and practice sessions with younger players. Roddick emphasized the benefits for injury prevention during training.

In a recent episode of the Served podcast, Andy Roddick addressed criticism of Serena Williams' use of GLP-1 medication for weight loss. He stated that if he were attempting a comeback, he would prioritize rapid weight reduction to facilitate safer training. "I can tell you something that I think I know for a fact, right? I’m not Serena. I can’t play anymore. I stink. And if I decided that I wanted to come back, guess what I would be doing immediately? Immediately, I’d be dropping 20 pounds as fast as I can," Roddick said.

Roddick argued that starting lighter reduces injury risks during preparation, which is a major hurdle for returning athletes. "I would be taking those drugs because you know what becomes easier when you are 20 pounds lighter? Actually, getting back to the training that you need without getting injured to get back on tour," he explained. He added, "What it does is shortens the timeline for training and mitigates a lot of the risk in because the thing with getting back is like you get injured training, injured training, injured training, you can’t get back. Right."

Williams first discussed her use of the medication in an August 2025 interview with People Magazine and reinforced it in a Super Bowl XL advertisement in 2026. In a January 2026 interview with Today.com, she highlighted health improvements: "My blood sugar is better. I was able to lower my cholesterol by 30%. Some of these numbers [previous high cholesterol levels] are from when I was literally winning Grand Slams. It wasn’t, like, just playing tennis. I was dominating. I was at risk for heart disease, and I didn’t even know. … That’s scary."

Comeback rumors intensified after Williams' name appeared in the tennis anti-doping testing pool, a step often required for returning players. On the Today show in January 2026, she responded ambiguously: "I’m just having fun and enjoying my life right now," adding, "I don’t know, I’m just going to see what happens."

American player Alycia Parks recently practiced with Williams and commented on her fitness. "I actually practiced with her last Monday. And I messaged her yesterday. She’s definitely a good mentor to me, and she’s helped me a lot, especially in my practices," Parks told Tennis Majors. She added, "She is in great shape. So I think she would kill it on tour."

Support for Williams continues to build in the tennis community as discussions of a potential return, possibly emulating sister Venus, persist.

مقالات ذات صلة

Serena Williams, fit and transformed, poses athletically with tennis racket against Super Bowl ad for Zepbound weight loss drug.
صورة مولدة بواسطة الذكاء الاصطناعي

Serena Williams appears in Super Bowl ad for weight loss medication

من إعداد الذكاء الاصطناعي صورة مولدة بواسطة الذكاء الاصطناعي

Serena Williams is set to feature in a Super Bowl commercial promoting the telehealth firm Ro and its GLP-1 weight loss medication Zepbound. The 44-year-old tennis legend discusses her body transformation, having lost up to 15.4kg since starting the treatment. The ad comes amid ongoing speculation about a potential return to professional tennis.

The International Tennis Integrity Agency has officially reinstated Serena Williams as an active player, removing her from the retired list on February 22, 2026. This move follows her rejoining the anti-doping testing pool last year, making her eligible for tournaments. Her former coach Rick Macci expressed certainty about a comeback, citing her intensive training.

من إعداد الذكاء الاصطناعي

نجم الكانتري جيلي رول خسر ما يقرب من 300 رطل على مدى عامين دون استخدام أدوية GLP-1 الشائعة مثل أوزمبيك. فتح المغني البالغ 41 عامًا قلبه في مجلة Men's Health حول مواجهة إدمانه على الطعام من خلال العلاج بدلاً من ذلك. من مشكلات التستوستيرون المنخفض إلى إعادة إشعال الرومانسية، إنه يسكب كل التفاصيل التحويلية.

ثلاث مراجعات كوكرين طُلبت من منظمة الصحة العالمية تقيم مثيرات مستقبلات GLP-1 مثل التيرزيباتيد والسيماغلوتايد والليراغلوتايد لفقدان الوزن لدى الأشخاص الذين يعانون من السمنة. تظهر الأدوية انخفاضًا كبيرًا في الوزن مقارنة بالدواء الوهمي، لكن الباحثين يشيرون إلى قيود في البيانات طويلة الأمد وتأثيرات تمويل الصناعة. الآثار الجانبية مثل الغثيان شائعة، مما يثير أسئلة حول الوصول الأوسع والسلامة.

من إعداد الذكاء الاصطناعي

Coco Gauff's quarterfinal exit at the 2026 Australian Open turned controversial when footage of her smashing her racket went viral. Tennis legend Serena Williams offered encouragement, while several players raised concerns about privacy in player areas. The incident highlighted the emotional pressures faced by athletes.

Top tennis players Carlos Alcaraz, Jannik Sinner and Aryna Sabalenka were instructed to remove their Whoop fitness trackers during the 2026 Australian Open. The devices, approved for ATP and WTA tours, remain banned at Grand Slams amid ongoing debates over player welfare and data rules. Tournament organizers are in discussions to potentially allow them in the future.

من إعداد الذكاء الاصطناعي

ناقشت لاعبة التنس المتقاعدة يوجيني بوكارد الفوضى في حياتها بعد وصولها إلى نهائي ويمبلدون 2014، الذي أحضر شهرة مفاجئة وتوقعات عالية. وصفت مرحلة تمرد شملت تغييرًا جذريًا في تسريحة شعرها، مما أدى إلى فقدان صفقة رعاية. الآن مركزة على البيكلبول، تؤكد بوكارد على التعقيد وراء صورتها العامة.

 

 

 

يستخدم هذا الموقع ملفات تعريف الارتباط

نستخدم ملفات تعريف الارتباط للتحليلات لتحسين موقعنا. اقرأ سياسة الخصوصية الخاصة بنا سياسة الخصوصية لمزيد من المعلومات.
رفض